COVID-19 and cystic fibrosis: Diagnostic difficulties or incorrect methods?

Samuel Pecho-Silva, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, Kovy Arteaga-Livias, Alfonso J. Rodriguez-Morales, Kuldeep Dhama

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.

Original languageEnglish
Pages (from-to)1681-1685
Number of pages5
JournalJournal of Pure and Applied Microbiology
Volume14
Issue number3
DOIs
StatePublished - Sep 2020

Keywords

  • COVID-19
  • Cystic fibrosis
  • Latin America
  • Pandemic
  • Peru
  • SARS-CoV-2
  • Serological tests

Fingerprint

Dive into the research topics of 'COVID-19 and cystic fibrosis: Diagnostic difficulties or incorrect methods?'. Together they form a unique fingerprint.

Cite this